Biostar Pharmaceuticals, Inc. (BSPM) Reaches $4.14 After 4.00% Down Move; Shorts at UNIV ENT CORPORATION (UETMF) Lowered By 6.37%

February 15, 2018 - By Marguerite Chambers

The stock of Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) is a huge mover today! The stock decreased 10.67% or $0.494 during the last trading session, reaching $4.136. About 305,293 shares traded. Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) has risen 57.27% since February 15, 2017 and is uptrending. It has outperformed by 40.57% the S&P500.The move comes after 8 months negative chart setup for the $10.91 million company. It was reported on Feb, 15 by We have $3.97 PT which if reached, will make NASDAQ:BSPM worth $436,280 less.

UNIV ENT CORPORATION (OTCMKTS:UETMF) had a decrease of 6.37% in short interest. UETMF’s SI was 1.03M shares in February as released by FINRA. Its down 6.37% from 1.10 million shares previously. With 100 avg volume, 10328 days are for UNIV ENT CORPORATION (OTCMKTS:UETMF)’s short sellers to cover UETMF’s short positions. It closed at $33.85 lastly. It is down 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Biostar Pharmaceuticals, Inc. develops, makes, and markets over-the-counter and prescription pharmaceutical products for various diseases and conditions in the PeopleÂ’s Republic of China. The company has market cap of $10.91 million. The firm principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It has a 12.16 P/E ratio. It also provides 12 other OTC products and 17 prescription pharmaceuticals.

Universal Entertainment Corporation plans, develops, makes, and sells Pachislot and Pachinko machines, and other game machines and peripheral equipment in Japan. The company has market cap of $. The firm also operates OKADA MANILA, casino resort business in the Philippines; Pachinko Pachislot TV!; and restaurants, as well as operates and manages online Shogi games. It currently has negative earnings. In addition, it distributes various applications on the SoftBank App pass.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Posts